m
Recent Posts
Connect with:
Friday / January 24.
HomeminewsACO–COT to Commence

ACO–COT to Commence

The Australian College of Optometry’s next Certificate in Ocular Therapeutics commences on 17 April. This will be the only Certificate in Ocular Therapeutics run by the College this year and places are limited.

Accredited by the Optometry Council of Australia and New Zealand and approved by the Optometry Board of Australia, successful completion of the ACO–COT enables scheduled medicines endorsement for registered optometrists in Australia and New Zealand. In 2016 the ACO–COT saw record enrolments and it is anticipated that 2017 enrolments will exceed this level.

Feedback from 2015 graduates found:

  • 100 per cent said their course expectations were achieved or exceeded
  • 100 per cent were satisfied or extremely satisfied with the course.

Speaking of the course, graduate John Adams said, “it worked well and the self-learning and study meant I could fit in the course around my work and family life. On a daily basis, I felt that the course made me more enthusiastic about work and meant I thought more closely about what I did and I feel it has made me a better optometrist.”

it worked well and the self-learning and study meant I could fit in the course around my work and family life

The ACO–COT is part of a suite of higher level certificate courses that the ACO is offering, including the Advanced Certificate in Glaucoma and the Certificate in Advanced Contact Lenses, commencing July.Once completed the ACO–COT carries 80 CPD points and 60 CE points in New Zealand.

Visit: aco.org.au/professional-development/ocular-therapeutics-course or phone (AUS) 03 9349 7477.

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.